Vistagen Therapeutics, Inc. VTGN
0.17 USD 0.00 +0.12%
As of Nov 2, 3:43 PM ET
0.1662 52-week range 5.14
- YTD
- -74.47%
- 1 year
- -95.72%
- Open
- 0.169
- Prev close
- 0.1683
- Mkt cap
- 7.48M
- Vol
- 730.18K
- Avg vol
- 12.32M
- EPS
- -1.66
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1662
- High
- 0.172
- Forward P/E
- -1.49
- Beta
- 0.00
- Short ratio
- 1.69
- Inst. own
- 53.63%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 11, 2025
- 50-d avg
- 2.81
- 200-d avg
- 3.60
- 1y target
- 13.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for VTGN has not been loaded yet. Try again in a moment.
Altman Z-Score
-24.25 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 5
P/E -0.3×
P/S 17.1×
P/B 0.6×
P/FCF -0.3×
EV/EBITDA 0.1×
EV/Sales -6.3×
FCF Yield -305.3%
Gross Margin 100.0%
Operating Margin -5683.7%
Net Margin -5491.3%
ROE -196.2%
ROIC -197.3%
ROA -143.5%
Revenue 161.1%
Operating Income -28.9%
EPS (diluted) -9.6%
Free Cash Flow -57.1%
Current Ratio 3.7×
Quick Ratio 3.7×
Debt / Equity 0.0×
Net Debt / EBITDA 0.4×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2026-03-31